Beta Bionics Investor Relations Material

Beta Bionics Inc is a U.S.-based medical technology company focused on the development of autonomous insulin delivery systems for people with diabetes. The company is developing the iLet Bionic Pancreas, an all-in-one wearable device designed to automate blood glucose management using insulin or a combination of insulin and glucagon. Beta Bionics aims to improve the quality of life for individuals with type 1 diabetes through advanced, user-friendly technologies. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.